News
In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...
Okanagan Clinical Trials is offering new opportunities for people to participate in important clinical research studies ...
18h
DPA International on MSNEMA recommends approval of additional Alzheimer's treatment
The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.
Dear Abby gives advice to a reader whose friend has been rude since being diagnosed with early Alzheimer’s disease.
Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...
The AFA opens a new Alzheimer’s support center in Amityville, offering programs, memory screenings and caregiver respite for ...
Without the receptor, ADGRG1, the microglia barely nibbled on the toxic protein. Using a mouse model of Alzheimer’s disease, the researchers observed how the loss of ADGRG1 led to the rapid buildup of ...
You shouldn’t shy away from managing your medical conditions, Prather said. Certain medical conditions, such as diabetes, ...
Typically, dietary copper plays a vital role in maintaining the health of your bones, nerves, blood vessels, and ability to ...
"Bleeds on the brain due to high blood pressure, or again, vessel damage. And all of these things, they interrupt the oxygen ...
Eli Lilly and Co. won the backing of European Union regulators for its Alzheimer’s disease drug Kisunla in a specific group ...
The European Medicines Agency has granted restricted EU authorization to Eli Lilly’s Alzheimer’s drug Kisunla, reversing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results